321 related articles for article (PubMed ID: 18281491)
21. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
[TBL] [Abstract][Full Text] [Related]
22. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress.
Barnett G; Jakobsen AM; Tas M; Rice K; Carmichael J; Murray JC
Cancer Res; 2000 Jun; 60(11):2850-7. PubMed ID: 10850427
[TBL] [Abstract][Full Text] [Related]
23. Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.
van Horssen R; Rens JA; Brunstein F; Guns V; van Gils M; Hagen TL; Eggermont AM
Int J Cancer; 2006 Sep; 119(6):1481-90. PubMed ID: 16615114
[TBL] [Abstract][Full Text] [Related]
24. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms.
Curnis F; Gasparri A; Sacchi A; Cattaneo A; Magni F; Corti A
Cancer Res; 2005 Apr; 65(7):2906-13. PubMed ID: 15805293
[TBL] [Abstract][Full Text] [Related]
26. Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts.
Reznikov AG; Chaykovskaya LV; Polyakova LI; Kornelyuk AI; Grygorenko VN
Exp Oncol; 2011 Dec; 33(4):231-4. PubMed ID: 22217713
[TBL] [Abstract][Full Text] [Related]
27. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis.
Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW
Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.
Seynhaeve AL; Hoving S; Schipper D; Vermeulen CE; de Wiel-Ambagtsheer Ga; van Tiel ST; Eggermont AM; Ten Hagen TL
Cancer Res; 2007 Oct; 67(19):9455-62. PubMed ID: 17909055
[TBL] [Abstract][Full Text] [Related]
29. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
30. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis.
Altan ZM; Denis D; Kagan D; Grund EM; Palmer SS; Nataraja SG
J Pharmacol Exp Ther; 2010 Aug; 334(2):460-6. PubMed ID: 20435921
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Winkelhake JL; Stampfl S; Zimmerman RJ
Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
[TBL] [Abstract][Full Text] [Related]
32. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
33. Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells.
Seynhaeve AL; Vermeulen CE; Eggermont AM; ten Hagen TL
Cell Biochem Biophys; 2006; 44(1):157-69. PubMed ID: 16456244
[TBL] [Abstract][Full Text] [Related]
34. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
35. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
[TBL] [Abstract][Full Text] [Related]
36. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
37. Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
Feleszko W; Lasek W; Gołab J; Jakóbisiak M
Neoplasma; 1995; 42(2):69-74. PubMed ID: 7617079
[TBL] [Abstract][Full Text] [Related]
38. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
[TBL] [Abstract][Full Text] [Related]
39. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.
Marvin MR; Libutti SK; Kayton M; Kao J; Hayward J; Grikscheit T; Fan Y; Brett J; Weinberg A; Nowygrod R; LoGerfo P; Feind C; Hansen KS; Schwartz M; Stern D; Chabot J
J Surg Res; 1996 Jun; 63(1):248-55. PubMed ID: 8661206
[TBL] [Abstract][Full Text] [Related]
40. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
